rxstat › Drug prices › Fostemsavir
Fostemsavir (Rukobia) price in Canada
No current shortage
Fostemsavir 600 mg tablet (extended-release) costs about $72.25 per tablet on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.
Fostemsavir has no current shortage reported in Canada. No active reports are on file.
Price by province
| Strength and form | AB |
|---|---|
| 600 mg Tablet (Extended-Release)per tablet | $72.25not covered |
| Plan coverage | Not covered |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 1 product
- Rukobia 600 mg Tablet (Extended-Release) · VIV
Shortage status
No shortage or discontinuation reports have been filed with Health Canada for Fostemsavir. rxstat watches those reports through the day; sign up below to hear if that changes.
Common questions
How much does Fostemsavir cost in Canada?
Fostemsavir 600 mg tablet (extended-release) costs about $72.25 per tablet on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.
Is Fostemsavir covered by provincial drug plans?
On the public plans' own lists: Alberta: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (direct acting antivirals)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.